Limerick-based pharma giant Regeneron posts better-than-expected earnings

The company expects the demand for its eye drug Eylea to lead to a strong third quarter even in the face of emerging competition from rival drugs. Picture: AP

Regeneron, the US pharma giant which employs around 1,400 people in Limerick, posted slightly better-than-expected earnings for Q2.

The company's quarterly revenue fell 44% to almost $2.86bn (€2.8bn), but came in just ahead of analysts' expectations of $2.8bn (€2.7bn).